Early T-ALL, also known as pre-T ALL, were first defined by the EGIL group [23], by the expression of the cCD3 T-cell lymphoid markers with/without CD2, CD5, and CD8, but negative for CD1a and sCD3. This evidence concerns the gene CD2 and acute lymphoblastic leukemia.